ArticleDiabetes, obesity & metabolism2025

Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study.

Chia-Ming Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.